What clinical trials led to updates in the treatment strategies for advanced/recurrent endometrial cancer?

Credit available for this activity expires: 3/9/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-update-advanced-recurrent-endometrial-cancer-how-2026a10006up?ecd=bdc_podcast_libsyn_mscpedu

Are you up to speed on emerging biomarkers? Join our expert panel to learn more about their clinical relevance and testing best practices

Credit available for this activity expires: 3/6/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-psma-preparing-your-practice-next-wave-prostate-2026a10006ql?ecd=bdc_podcast_libsyn_mscpedu

Do you know how many seizures is too many? Or what drugs to avoid in older epilepsy patients?

Credit available for this activity expires: 3/3/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/avoiding-common-mistakes-managing-focal-epilepsy-2026a10004kv?ecd=bdc_podcast_libsyn_mscpedu

Are you optimizing inhaler choice and technique to achieve better outcomes?

Credit available for this activity expires: 2/27/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/prescription-practice-respiratory-diseases-overcoming-2026a100058h?ecd=bdc_podcast_libsyn_mscpedu

Do you know how person-centred care can help address the challenges faced by chronic lymphocytic leukaemia (CLL) patients? Credit available for this activity expires: 02/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cll-consultation-partnering-patients-person-centred-care-2026a10005ap?ecd=bdc_podcast_libsyn_mscpedu

Did you know that combining Bacillus Calmette-Guérin (BCG) with immunotherapy significantly improves outcomes in high-risk bladder cancer?

Credit available for this activity expires: 2/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/immunotherapy-non-muscle-invasive-bladder-cancer-expert-2026a10005af?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on HER2 testing best practices? Join our expert panel and discover the critical updates that guide treatment selection.

Credit available for this activity expires: 2/17/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-her2-spectrum-breast-cancer-evolving-diagnostic-2026a10004ea?ecd=bdc_podcast_libsyn_mscpedu

What do the latest data from the 2025 breast cancer Winter Conference tell us?

Credit available for this activity expires: 02/02/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/winter-conference-update-novel-and-emerging-treatment-2026a100030r?ecd=bdc_podcast_libsyn_mscpedu

Known as a "silent" disease because it has few or no symptoms, MASH increases cirrhosis, cancer, and death rates despite being both detectable and treatable.

Credit available for this activity expires: 01/30/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/case-based-journey-risk-results-2026a10002fy?ecd=bdc_podcast_libsyn_mscpedu

Are you up-to-date on the latest data in HER2-positive early breast cancer? Join our experts as they discuss the data and the clinical implications!

Credit available for this activity expires: 01/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-positive-early-breast-cancer-what-latest-data-mean-your-2026a10002fg?ecd=bdc_podcast_libsyn_mscpedu